🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Glaucoma is one of the leading causes of blindness worldwide that is a chro...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT03966560
The purpose of this study is to assess the safety and efficacy of switching...
Status
Completed
Location
Youngnam Univ. Hospital
Start Date
2010-03
Trial ID
NCT01055366
Treatments Being Tested
The purpose of this study was to assess patient preference regarding ocular...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01340014
Uncontrolled glaucoma patients being treated with a prostaglandin agent alo...
Status
Completed
Location
Sydney Study Site
Start Date
2006-09
Trial ID
NCT00382226
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of Brinzo...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01310777
Glaucoma is a progressive disease resulting in blindness. Determining the o...
Status
Terminated
Location
Bascom Palmer Eye Institute - University of Miami
Start Date
2015-09
Trial ID
NCT02390284
Treatments Being Tested
To compare the efficacy and safety of Perrigo's product to an FDA approved ...
Status
Completed
Location
James D. Branch Ophthalmology
Start Date
2021-05-28
Trial ID
NCT04944290
Treatments Being Tested
The purpose of this study is to compare the fixed combination (BID) \[Brinz...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-14
Trial ID
NCT02339584
The purpose of this study is to demonstrate the additive effect of brinzola...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01937299
To compare the efficacy of a Brinzolamide/Brimonidine fixed combination (FC...
Status
Completed
Location
University Hospital of Patras
Start Date
2016-06-20
Trial ID
NCT03192826
Treatments Being Tested